Antifolate
<div class="colum_1 clearer"><p>Antifolates are compounds that antagonise the actions of folic acid (vitamin B9). Folic acid's primary function in the body is as a cofactor to various methyltransferases involved in serine, methionine, thymidine and purine biosynthesis. Consequently antifolates inhibit cell division, DNA/RNA synthesis and repair and protein synthesis. Some such as Proguanil, Pyrimethamine and Trimethoprim selectively inhibit folate's actions in microbial organisms such as bacteria, protozoa and fungi. The majority of antifolates work by inhibiting dihydrofolate reductase (DHFR). Many are primarily DHFR inhibitors, but Raltitrexed is an inhibitor of thymidylate synthase, and Pemetrexed inhibits both and a third enzyme. Antifolates act specifically during DNA and RNA synthesis, and thus are cytotoxic during the S-phase of the cell cycle. Thus, they have a greater toxic effect on rapidly dividing cells.</p></div>
Targets for Antifolate
Products for Antifolate
- Cat.No. Product Name Information
-
GC42789
Aminopterin
4-amino Folic Acid, 4-amino PGA, APGA, NSC 739
Aminopterin is a synthetic folic acid derivative whose metabolite is a competitive inhibitor of dihydrofolate reductase, which is a cofactor for nucleic acid synthesis. -
GC15306
Calcium N5-methyltetrahydrofolate
Calcium salt of levomefolic acid
-
GC34309
Cycloguanil D6 (Chlorguanide triazine D6)
-
GC35781
Cycloguanil D6 Nitrate
Chlorguanide triazine D6 Nitrate
Cycloguanil D6 Nitrate is the deuterium labeled Cycloguanil, which is a dihydrofolate reductase inhibitor. -
GC65617
DHFR-IN-3
DHFR-IN-3 is a dihydrofolate reductase (DHFR) inhibitor with the IC50 values of 19 μM and 12 μM in rat liver and P. carinii DHFR, respectively.
-
GC32343
Diaveridine (EGIS-5645)
NSC 408735
Diaveridine (EGIS-5645) (EGIS-5645) is a dihydrofolate reductase (DHFR) inhibitor with a Ki of 11.5 nM for the wild type DHFR and also an antibacterial agent. -
GC19495
DL-Folinic Acid (calcium salt)
DL-Folinate NSC 3590
DL-Folinic Acid (calcium salt) (Leucovorin calcium) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity. -
GC32401
EC0489
EC0489, a conjugate of folic acid and desacetyl vinblastine hydrazide, is a high-affinity ligand for the folate receptor (FR). Refractory or metastatic Tumor. Small molecule-drug conjugate (SMDC).
-
GC62968
Fanotaprim
VYR-006
Fanotaprim is a dihydrofolate reductase (DHFR) inhibitor with IC50s of 1.57 and 308 nM for tgDHFR (Toxoplasma gondii DHFR) and hDHFR (human DHFR), respectively. -
GC14331
Folinic acid
NULL
-
GC16203
Leucovorin Calcium
Leucovorin Calcium (Leucovorin calcium salt pentahydrate) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity.
-
GC16680
Levoleucovorin Calcium
L-Folinate, 5-Formyltetrahydrofolate
Levoleucovorin Calcium (Calcium levofolinate), a levo isoform of Leucovorin Calcium, possesses antineoplastic effects. Levoleucovorin Calcium is also an augmentor of 5-fluorouracil cytotoxicity against cancer. -
GC11558
Levomefolate calcium
A biologically active form of folic acid
-
GC18404
Lometrexol
Glycinamide ribonucleotide formyltransferase (GART) is a folate-dependent enzyme required for de novo purine synthesis.
-
GC66387
Lometrexol disodium
DDATHF disodium
Lometrexol (DDATHF) disodium, an antipurine antifolate, can inhibit the activity of glycinamide ribonucleotide formyltransferase (GARFT) but do not induce detectable levels of DNA strand breaks. Lometrexol disodium can further inhibit de novo purine synthesis, causing abnormal cell proliferation and apoptosis, even cell cycle arrest. Lometrexol disodium has anticancer activity. Lometrexol disodium also is a potent human Serine hydroxymethyltransferase1/2 (hSHMT1/2) inhibitor. -
GC39820
Lometrexol hydrate
DDATHF, (6R)-Dideazatetrahydrofolate
A GART inhibitor -
GC36486
LSN 3213128
LSN 3213128 is a selective, nonclassical, orally bioavailable antifolate with potent and specific inhibitory activity for aminoimidazole-4-carboxamide ribonucleotide formyltransferase (AICARFT), with IC50 of 16 nM for AICARFT enzyme inhibiton and 19 nM in cells. Anti-tumor activity.
-
GC33322
LY 254155
LY 254155, an antifolate, inhibits hGARFT and binds to mFBP with Kis of 2.1±0.2 and 1.7±0.1 nM, respectively.
-
GC33373
LY309887
LY309887 is a potent inhibitor of glycinamide ribonucleotide formyltransferase (GARFT), with a Ki of 6.5 nM, and has antitumor activity.
-
GC10405
Methotrexate
Methotrexate is an antifolate antimetabolite that effectively inhibits the activity of dihydrofolate reductase (DHFR), with an IC50 of approximately 7nM.
-
GC61047
Methotrexate disodium
Methotrexate (Amethopterin) disodium, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis.
-
GC36589
Methotrexate metabolite
DAMPA
Methotrexate metabolite (DAMPA), the active metabolite of Methotrexate. -
GC61058
Metoprine
Metoprine (BW 197U) is a potent histamine N-methyltransferase (HMT) inhibitor.
-
GC69466
Mirvetuximab
M9346A
Mirvetuximab (M9346A) is a monoclonal antibody that targets anti-FOLR1 (folate receptor 1). Mirvetuximab is an antibody molecule for a novel folate receptor alpha (FRα)-targeting ADC (Mirvetuximab soravtansine). Mirvetuximab soravtansine can be used in ovarian cancer and other FRα-positive cancer research.
-
GC73018
Mirvetuximab soravtansine (solution)
IMGN853 (solution
Mirvetuximab soravtansine (IMGN853) solution is an anti-folate receptor α (FRα) ADC consisting of the cytotoxic maytansinoid, DM4, covalently linked to the humanized monoclonal antibody M9346A. -
GC11610
Pemetrexed
Pemetrexed (also known as pemetrexed disodium) is a novel antifolate antimetabolite targeting multiple enzymes involved in both pyrimidine and purine synthesis.
-
GC17694
Pemetrexed disodium hemipenta hydrate
-
GC12919
Pralatrexate
NSC 754230, PDX, 10-Propargyl-10-deazaaminopterin
A dihydrofolate reductase inhibitor -
GC17867
Pyrimethamine
Darapram, Daraprim, Khloridin, NSC 3061
A dihydrofolate reductase inhibitor -
GC63612
Tetroxoprim
Tetroxoprim is an antimicrobial DHFR inhibitor.
-
GC10137
Trimethoprim
NIH 204, NSC 106568
bacteriostatic antibiotic -
GC66422
Trimethoprim-d9
Trimethoprim-d9 is the deuterium labeled Trimethoprim. Trimethoprim is a bacteriostatic antibiotic and an orally active dihydrofolate reductase inhibitor. Trimethoprim is active against a wide range of Gram-positive and Gram-negative aerobic bacteria. Trimethoprim has the potential for urinary tract infections, Shigellosis and Pneumocystis pneumonia treatment.
-
GC37938
WR99210
BRL 6231 free base
WR99210 is an orally active and low-toxicity dihydrofolate reductase (DHFR) inhibitor (IC50<0.075 nM).